Pulmonary Hypertension & Lung Disease

Trial Objective

Pulmonary Hypertension & Lung DiseaseThe purpose of this clinical trial is to determine the safety and effectiveness of an inhaled investigational medication, Treprostinil, in treating pulmonary hypertension related to Interstitial Lung Disease (ILD), including Combined Pulmonary Fibrosis and Emphysema (CPFE).

Enrollment

This trial is active and currently recruiting.

Who Can Participate

Individuals with pulmonary hypertension related to interstitial lung disease (ILD), including combined pulmonary fibrosis and emphysema (CPFE).

Age: 18+    Gender: Any Gender


Estimated Time Commitment

7 visits over 20 weeks



Compensation

Provided

Trial Contact

For more information, contact:

Kris Eliopoulos

Kris Eliopoulos
303.398.2622

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

United Therapeutics Corporation

Principal Investigators


Request More Information

*
*
*
*